NYSE$FMC

FMC Corp · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

FMC delivered strong third quarter results and confirmed 2021 guidance, reporting significant growth in revenue and profitability.

FMC Corporation reported a strong third quarter with revenue of $1.19 billion, a 10% increase compared to Q3 2020. Consolidated GAAP net income was $160 million, up 43% versus Q3 2020, and adjusted earnings per diluted share were $1.43, up 17% versus Q3 2020. The company maintains its full-year guidance and remains confident in its ability to deliver the fourth quarter forecast.

  • Revenue of $1.19 billion, an increase of 10 percent versus Q3 2020 and up 9 percent organically
  • Consolidated GAAP net income of $160 million, up 43 percent versus Q3 2020
  • Adjusted EBITDA of $293 million, up 12 percent versus Q3 2020
  • Consolidated adjusted earnings per diluted share of $1.43, up 17 percent versus Q3 2020

Headline financials

Total Revenue

$1.19B

Previous: $1.08B+10.1%
EPS (adj)

$1.43

Previous: $1.22+17.2%
Organic Revenue Change (non-GAAP)

9.0%

No prior period
Capital Expenditures

-$76.4M

Previous: -$35.2M-117.0%
Free Cash Flow

$81.5M

Previous: $76.2M+7.0%
Net Income

$158M

Previous: $111M+41.7%
Operating Income

$217M

Previous: $196M+10.7%
Gross Profit

$513M

Previous: $466M+9.9%
Cash & Equivalents

$341M

Previous: $297M+14.8%
Total Assets

$10.4B

Previous: $9.77B+6.5%
Stock-Based Comp

$3.8M

Previous: $3.9M-2.6%

Revenue & EPS history

FMC · Revenue · Quarterly

$1.19B

Q3 2021+10.1%vs Q3 2020
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Forward guidance

FMC maintains its forecast for full-year 2021 revenue to be in the range of $4.9 billion to $5.1 billion, representing an 8 percent increase at the midpoint versus 2020. Full-year adjusted EBITDA is expected to be in the range of $1.29 billion to $1.35 billion, representing a 6 percent year-over-year growth at the midpoint. 2021 adjusted earnings is now expected to be in the range of $6.59 to $6.99 per diluted share, up 10 percent at the midpoint, reflecting the impact of share repurchases completed year-to-date.

Tailwinds

  • Full-year earnings growth can be attributed to strong volume growth of higher margin products
  • Full-year earnings growth can be attributed to the launch of new products including XywayTM fungicide, Overwatch® herbicide and VantacorTM insect control
  • Full-year earnings growth can be attributed to price increases.
  • Fourth quarter revenue is expected to be in the range of $1.27 billion to $1.47 billion, representing a 19 percent increase at the midpoint compared to fourth quarter 2020 and organic growth of 19 percent.
  • FMC expects adjusted earnings per diluted share to be in the range of $1.80 to $2.20 in the fourth quarter, which represents growth of 41 percent at the midpoint versus fourth quarter 2020.

Headwinds

  • Full-year free cash flow is expected to be $480 million to $570 million and the company expects to repurchase $350 million to $450 million of FMC shares in 2021, including the $300 million repurchased through September.
  • We are maintaining our full-year guidance and remain confident in our ability to deliver the fourth quarter forecast driven by high margin volume growth and accelerating price increases, despite the volatile supply conditions in crop protection and other industries.
  • Adjusted EBITDA is forecasted to be in the range of $343 million to $403 million, representing a 29 percent increase at the midpoint versus fourth quarter 2020.
  • The company expects to repurchase $50 million to $150 million of FMC shares in the quarter.
  • Reiterates free cash flow forecast in the range of $480 to $570 million, reflecting a 4 percent decline at the midpoint versus 2020

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

-1.0%

Avg return

Earnings day

-1.0%

Avg return

5 days after

-0.9%

Avg return

30 days after

49%

35 / 72 earnings

Positive

+12.6%

Q3 2021

Best reaction

-46.5%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+7.3%+1.5%-6.8%
Q4 2025-19.5%-5.8%-17.4%
Q3 2025-46.5%-53.8%-50.8%
Q1 2025-8.3%-15.0%-3.2%
Q4 2024-33.5%-35.0%-23.6%
Q3 2024+8.3%+2.6%-3.3%
Q2 2024+10.0%+5.5%+10.4%
Q1 2024+7.9%+9.2%-6.5%
Q4 2023-13.0%-15.8%+0.1%
Q3 2023-6.5%-2.6%-7.4%
Q2 2023-3.2%-3.2%-8.4%
Q1 2023-5.8%-8.2%-15.8%
Q4 2022+1.9%+4.0%-2.3%
Q3 2022+0.8%+4.7%+9.4%
Q2 2022-0.1%-2.5%-2.1%
Q1 2022-6.8%-10.2%-8.2%
Q4 2021+8.5%+8.9%+15.0%
Q3 2021+12.6%+14.1%+10.8%
Q2 2021-7.5%-10.6%-9.3%
Q1 2021-1.4%-0.6%-0.6%
Q4 2020-7.5%-7.7%-6.8%
Q3 2020+1.9%+5.8%+15.0%
Q2 2020+1.2%+3.8%+3.5%
Q1 2020+2.6%+4.3%+11.3%
Q4 2019+9.0%+5.9%-8.5%
Q3 2019+8.3%+13.1%+17.6%
Q2 2019+2.8%+2.2%+1.7%
Q1 2019+1.2%+2.4%+1.4%
Q4 2018-2.7%+5.4%+12.2%
Q3 2018+3.9%+3.9%+3.4%
Q2 2018-3.7%-2.0%-4.9%
Q1 2018+4.9%+10.0%+10.6%
Q4 2017-1.0%+0.8%+0.0%
Q3 2017+2.6%+2.3%-3.4%
Q2 2017+9.8%+10.4%+12.9%
Q1 2017-3.0%-0.3%+3.6%
Q4 2016-5.4%-4.1%-3.3%
Q3 2016+7.9%+13.5%+19.8%
Q2 2016+2.0%+2.1%-1.2%
Q1 2016+9.4%
Q4 2015-2.9%
Q3 2015+9.6%
Q2 2015+0.8%
Q1 2015-5.2%
Q4 2014+4.4%
Q3 2014+0.6%
Q2 2014-4.1%
Q1 2014-3.7%
Q4 2013+2.9%
Q3 2013-1.5%
Q2 2013+3.2%
Q1 2013-3.8%
Q4 2012-4.5%
Q3 2012-1.4%
Q2 2012-3.6%
Q1 2012-2.3%
Q4 2011+2.1%
Q3 2011+7.0%
Q2 2011-5.8%
Q1 2011+1.6%
Q4 2010-6.5%
Q3 2010+1.7%
Q2 2010+1.5%
Q1 2010-0.0%
Q1 2009-0.0%
Q4 2007-2.5%
Q4 2009-2.5%
Q3 2009+0.8%
Q3 2008+0.8%
Q2 2008-2.5%
Q4 2008-2.5%
Q2 2009-2.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro